Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 2007, 57: 43–66. 10.3322/canjclin.57.1.43
Article
PubMed
Google Scholar
National Cancer Institute
[http://www.cancer.gov]
Parkin DM: Global cancer statistics in the year 2000. Lancet Oncol 2001, 2: 533–543. 10.1016/S1470-2045(01)00486-7
Article
CAS
PubMed
Google Scholar
National Institute for Clinical Excellence
[http://www.nice.org]
Hughes KS, Simon R, Songhorabodi S, Adson MA, Ilstrup DM, Fortner JG, Maclean BJ, Foster JH, Daly JM, Fitzherbert D: Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 1986, 100: 278–284.
CAS
PubMed
Google Scholar
Ruers TJ, Wiering B, van der Sijp JR, Roumen RM, de Jong KP, Comans EF, Pruim J, Dekker HM, Krabbe PF, Oyen WJ: Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study. J Nucl Med 2009, 50: 1036–1041. 10.2967/jnumed.109.063040
Article
PubMed
Google Scholar
Jain RK: Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. Cancer Res 1990, 50: 814s-819s.
CAS
PubMed
Google Scholar
Reardan DT, Meares CF, Goodwin DA, McTigue M, David GS, Stone MR, Leung JP, Bartholomew RM, Frincke JM: Antibodies against metal chelates. Nature 1985, 316: 265–268. 10.1038/316265a0
Article
CAS
PubMed
Google Scholar
Boerman OC, van Schaijk FG, Oyen WJ, Corstens FH: Pretargeted radioimmunotherapy of cancer: progress step by step. J Nucl Med 2003, 44: 400–411.
PubMed
Google Scholar
Chang CH, Sharkey RM, Rossi EA, Karacay H, McBride W, Hansen HJ, Chatal JF, Barbet J, Goldenberg DM: Molecular advances in pretargeting radioimunotherapy with bispecific antibodies. Mol Cancer Ther 2002, 1: 553–563.
CAS
PubMed
Google Scholar
Sharkey RM, Cardillo TM, Rossi EA, Chang CH, Karacay H, McBride WJ, Hansen HJ, Horak ID, Goldenberg DM: Signal amplification in molecular imaging by pretargeting a multivalent, bispecific antibody. Nat Med 2005, 11: 1250–1255. 10.1038/nm1322
Article
CAS
PubMed
Google Scholar
Le Doussal JM, Martin M, Gautherot E, Delaage M, Barbet J: In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: enhanced divalent hapten affinity for cell-bound antibody conjugate. J Nucl Med 1989, 30: 1358–1366.
CAS
PubMed
Google Scholar
Karacay H, McBride WJ, Griffiths GL, Sharkey RM, Barbet J, Hansen HJ, Goldenberg DM: Experimental pretargeting studies of cancer with a humanized anti-CEA × murine anti-[In-DTPA] bispecific antibody construct and a (99 m)Tc-/(188)Re-labeled peptide. Bioconjug Chem 2000, 11: 842–854. 10.1021/bc0000379
Article
CAS
PubMed
Google Scholar
Wiering B, Krabbe PF, Jager GJ, Oyen WJ, Ruers TJ: The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases. Cancer 2005, 104: 2658–2670. 10.1002/cncr.21569
Article
PubMed
Google Scholar
Park IJ, Kim HC, Yu CS, Ryu MH, Chang HM, Kim JH, Ryu JS, Yeo JS, Kim JC: Efficacy of PET/CT in the accurate evaluation of primary colorectal carcinoma. Eur J Surg Oncol 2006, 32: 941–947. 10.1016/j.ejso.2006.05.019
Article
CAS
PubMed
Google Scholar
Llamas-Elvira JM, Rodriguez-Fernandez A, Gutierrez-Sainz J, Gomez-Rio M, Bellon-Guardia M, Ramos-Font C, Rebollo-Aguirre AC, Cabello-Garcia D, Ferron-Orihuela A: Fluorine-18 fluorodeoxyglucose PET in the preoperative staging of colorectal cancer. Eur J Nucl Med Mol Imaging 2007, 34: 859–867. 10.1007/s00259-006-0274-4
Article
CAS
PubMed
Google Scholar
Tzimas GN, Koumanis DJ, Meterissian S: Positron emission tomography and colorectal carcinoma: an update. J Am Coll Surg 2004, 198: 645–652. 10.1016/j.jamcollsurg.2003.11.015
Article
PubMed
Google Scholar
Topal B, Flamen P, Aerts R, D'Hoore A, Filez L, Van Cutsem E, Mortelmans L, Penninckx F: Clinical value of whole-body emission tomography in potentially curable colorectal liver metastases. Eur J Surg Oncol 2001, 27: 175–179. 10.1053/ejso.2000.1075
Article
CAS
PubMed
Google Scholar
Pelosi E, Deandreis D: The role of 18F-fluoro-deoxy-glucose positron emission tomography (FDG-PET) in the management of patients with colorectal cancer. Eur J Surg Oncol 2007, 33: 1–6. 10.1016/j.ejso.2006.10.020
Article
CAS
PubMed
Google Scholar
Herbertson RA, Scarsbrook AF, Lee ST, Tebbutt N, Scott AM: Established, emerging and future roles of PET/CT in the management of colorectal cancer. Clin Radiol 2009, 64: 225–237. 10.1016/j.crad.2008.08.008
Article
CAS
PubMed
Google Scholar
Rosenbaum SJ, Lind T, Antoch G, Bockisch A: False-positive FDG PET uptake--the role of PET/CT. Eur Radiol 2006, 16: 1054–1065. 10.1007/s00330-005-0088-y
Article
PubMed
Google Scholar
Metser U, Miller E, Lerman H, Even-Sapir E: Benign nonphysiologic lesions with increased 18F-FDG uptake on PET/CT: characterization and incidence. AJR Am J Roentgenol 2007, 189: 1203–1210. 10.2214/AJR.07.2083
Article
PubMed
Google Scholar
Even-Sapir E, Parag Y, Lerman H, Gutman M, Levine C, Rabau M, Figer A, Metser U: Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology 2004, 232: 815–822. 10.1148/radiol.2323031065
Article
PubMed
Google Scholar
Dirisamer A, Schima W, Heinisch M, Weber M, Lehner HP, Haller J, Langsteger W: Detection of histologically proven peritoneal carcinomatosis with fused 18F-FDG-PET/MDCT. Eur J Radiol 2009, 69: 536–541. 10.1016/j.ejrad.2007.11.032
Article
PubMed
Google Scholar
Goldenberg DM, Rossi EA, Sharkey RM, McBride WJ, Chang CH: Multifunctional antibodies by the Dock-and-Lock method for improved cancer imaging and therapy by pretargeting. J Nucl Med 2008, 49: 158–163.
Article
CAS
PubMed
Google Scholar
Lindmo T, Boven E, Cuttitta F, Fedorko J, Bunn PA Jr: Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J Immunol Methods 1984, 72: 77–89. 10.1016/0022-1759(84)90435-6
Article
CAS
PubMed
Google Scholar
Morel A, Darmon M, Delaage M: Recognition of imidazole and histamine derivatives by monoclonal antibodies. Mol Immunol 1990, 27: 995–1000. 10.1016/0161-5890(90)90122-G
Article
CAS
PubMed
Google Scholar
Rossi EA, Goldenberg DM, Cardillo TM, McBride WJ, Sharkey RM, Chang CH: Stably tethered multifunctional structures of defined composition made by the dock and lock method for use in cancer targeting. Proc Natl Acad Sci USA 2006, 103: 6841–6846. 10.1073/pnas.0600982103
Article
CAS
PubMed Central
PubMed
Google Scholar
Sharkey RM, Goldenberg DM, Goldenberg H, Lee RE, Ballance C, Pawlyk D, Varga D, Hansen HJ: Murine monoclonal antibodies against carcinoembryonic antigen: immunological, pharmacokinetic, and targeting properties in humans. Cancer Res 1990, 50: 2823–2831.
CAS
PubMed
Google Scholar
McBride WJ, Zanzonico P, Sharkey RM, Noren C, Karacay H, Rossi EA, Losman MJ, Brard PY, Chang CH, Larson SM, Goldenberg DM: Bispecific antibody pretargeting PET (immunoPET) with an 124I-labeled hapten-peptide. J Nucl Med 2006, 47: 1678–1688.
CAS
PubMed
Google Scholar
Fraker PJ, Speck JC Jr: Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun 1978, 80: 849–857. 10.1016/0006-291X(78)91322-0
Article
CAS
PubMed
Google Scholar
Schoffelen R, Sharkey RM, Goldenberg DM, Franssen G, McBride WJ, Rossi EA, Chang CH, Laverman P, Disselhorst JA, Eek A, van der Graaf WT, Oyen WJ, Boerman OC: Pretargeted immuno-positron emission tomography imaging of carcinoembryonic antigen-expressing tumors with a bispecific antibody and a 68Ga- and 18F-labeled hapten peptide in mice with human tumor xenografts. Mol Cancer Ther 2010, 9: 1019–1027. 10.1158/1535-7163.MCT-09-0862
Article
CAS
PubMed Central
PubMed
Google Scholar
Visser EP, Disselhorst JA, Brom M, Laverman P, Gotthardt M, Oyen WJ, Boerman OC: Spatial resolution and sensitivity of the Inveon small-animal PET scanner. J Nucl Med 2009, 50: 139–147.
Article
PubMed
Google Scholar
Koppe MJ, Hendriks T, Boerman OC, Oyen WJ, Bleichrodt RP: Radioimmunotherapy is an effective adjuvant treatment after cytoreductive surgery of experimental colonic peritoneal carcinomatosis. J Nucl Med 2006, 47: 1867–1874.
CAS
PubMed
Google Scholar
Meyers MA: Dynamic radiology of the abdomen: normal and pathologic anatomy. 5th edition. New York: Springer-Verlag; 2000.
Google Scholar
De Gaetano AM, Calcagni ML, Rufini V, Valenza V, Giordano A, Bonomo L: Imaging of peritoneal carcinomatosis with FDG PET-CT: diagnostic patterns, case examples and pitfalls. Abdom Imaging 2009, 34: 391–402. 10.1007/s00261-008-9405-7
Article
PubMed
Google Scholar
Schoffelen R, van der Graaf WT, Franssen G, Sharkey RM, Goldenberg DM, McBride WJ, Rossi EA, Eek A, Oyen WJ, Boerman OC: Pretargeted 177Lu radioimmunotherapy of carcinoembryonic antigen-expressing human colonic tumors in mice. J Nucl Med 2010, 51: 1780–1787. 10.2967/jnumed.110.079376
Article
PubMed
Google Scholar
Sharkey RM, Primus FJ, Goldenberg DM: Antibody protein dose and radioimmunodetection of GW-39 human colon tumor xenografts. Int J Cancer 1987, 39: 611–617. 10.1002/ijc.2910390512
Article
CAS
PubMed
Google Scholar
Moshakis V, McIlhinney RA, Raghavan D, Neville AM: Localization of human tumour xenografts after i.v. administration of radiolabeled monoclonal antibodies. Br J Cancer 1981, 44: 91–99. 10.1038/bjc.1981.153
Article
CAS
PubMed Central
PubMed
Google Scholar
Hagan PL, Halpern SE, Dillman RO, Shawler DL, Johnson DE, Chen A, Krishnan L, Frincke J, Bartholomew RM, David GS, Carlo D: Tumor size: effect on monoclonal antibody uptake in tumor models. J Nucl Med 1986, 27: 422–427.
CAS
PubMed
Google Scholar
Blumenthal RD, Sharkey RM, Kashi R, Natale AM, Goldenberg DM: Influence of animal host and tumor implantation site on radio-antibody uptake in the GW-39 human colonic cancer xenograft. Int J Cancer 1989, 44: 1041–1047. 10.1002/ijc.2910440617
Article
CAS
PubMed
Google Scholar
Sharkey RM, Karacay H, Vallabhajosula S, McBride WJ, Rossi EA, Chang CH, Goldsmith SJ, Goldenberg DM: Metastatic human colonic carcinoma: molecular imaging with pretargeted SPECT and PET in a mouse model. Radiology 2008, 246: 497–507. 10.1148/radiol.2462070229
Article
PubMed
Google Scholar
Chowdhury FU, Shah N, Scarsbrook AF, Bradley KM: [18F]FDG PET/CT imaging of colorectal cancer: a pictorial review. Postgrad Med J 2010, 86: 174–182. 10.1136/pgmj.2009.079087
Article
PubMed
Google Scholar
Esteves FP, Schuster DM, Halkar RK: Gastrointestinal tract malignancies and positron emission tomography: an overview. Semin Nucl Med 2006, 36: 169–181. 10.1053/j.semnuclmed.2005.12.002
Article
PubMed
Google Scholar
Fueger BJ, Czernin J, Hildebrandt I, Tran C, Halpern BS, Stout D, Phelps ME, Weber WA: Impact of animal handling on the results of 18F-FDG PET studies in mice. J Nucl Med 2006, 47: 999–1006.
CAS
PubMed
Google Scholar
McBride WJ, Sharkey RM, Karacay H, D'Souza CA, Rossi EA, Laverman P, Chang CH, Boerman OC, Goldenberg DM: A novel method of 18F radiolabeling for PET. J Nucl Med 2009, 50: 991–998. 10.2967/jnumed.108.060418
Article
CAS
PubMed
Google Scholar
Laverman P, McBride WJ, Sharkey RM, Eek A, Joosten L, Oyen WJ, Goldenberg DM, Boerman OC: A novel facile method of labeling octreotide with (18)F-fluorine. J Nucl Med 2010, 51: 454–461. 10.2967/jnumed.109.066902
Article
CAS
PubMed Central
PubMed
Google Scholar